HomeABVC • NASDAQ
ABVC Biopharma Inc
add
$1.21
17.12%
After Hours:(0.83%)-0.0100
$1.20
Closed: May 15, 6:01:34 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 693.01K | -75.59% |
Net income | -842.08K | 70.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -685.98K | 75.82% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.26K | 104.18% |
Total assets | 14.88M | 2.87% |
Total liabilities | 6.92M | -0.77% |
Total equity | 7.96M | — |
Shares outstanding | 16.04M | — |
Price to book | 3.95 | — |
Return on assets | -15.46% | — |
Return on capital | -23.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -842.08K | 70.29% |
Cash from operations | -539.83K | 43.52% |
Cash from investing | — | — |
Cash from financing | 428.76K | -53.61% |
Net change in cash | -104.25K | -80.43% |
Free cash flow | 621.88K | 7.99% |
Previous close
$1.46
Day range
$1.14 - $1.48
Year range
$0.40 - $1.79
Market cap
20.30M USD
Avg Volume
458.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
18
